← Back to catalogue

Motiva® SmoothSilk® Round Ergonomix Breast Implant

FDA UDI

Class III (US FDA UDI)

by Establishment Labs S.A.

Identity

Trade Name
Motiva® SmoothSilk® Round Ergonomix Breast Implant FDA UDI
Generic Name
Silicone gel-filled breast implant, smooth-surface FDA UDI
Device Name
Motiva® SmoothSilk® Round Ergonomix Breast Implant Round Ergonomix Breast Implant - Demi with Qid 190 cc FDA UDI
Model / Reference
ERSD-190Q FDA UDI
Description
Motiva® SmoothSilk® Round Ergonomix Breast Implant Round Ergonomix Breast Implant - Demi with Qid 190 cc FDA UDI

Identifiers

Catalog Number
ERSD-190Q FDA UDI
Primary DI / UDI-DI
07445161012098 FDA UDI
PMA Number
P230005 FDA UDI
FDA Product Code
FTR FDA UDI
GMDN Term
Silicone gel-filled breast implant, smooth-surface FDA UDI

Classification

Device Class
Class III FDA UDI
Regulation Number
878.3540 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

Yes

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI
Sterilization Method
Dry Heat Sterilization FDA UDI
MRI Safety
MR Conditional FDA UDI

Category: Silicone gel-filled breast implant, smooth-surface

A comprehensive overview of the Motiva SmoothSilk Round Ergonomix Breast Implant, including its features, regulatory compliance, and more.

Similar devices

Also classified as Silicone gel-filled breast implant, smooth-surface.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI b18dd8b2-c9ca-4391-a5ce-35e2a13f1ca1 35 fields · synced Oct 6, 2026